Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Management of epilepsy associated with tuberous sclerosis complex: Updated clinical recommendations.

Curatolo P, Nabbout R, Lagae L, Aronica E, Ferreira JC, Feucht M, Hertzberg C, Jansen AC, Jansen F, Kotulska K, Moavero R, O'Callaghan F, Papavasiliou A, Tzadok M, Jóźwiak S.

Eur J Paediatr Neurol. 2018 Sep;22(5):738-748. doi: 10.1016/j.ejpn.2018.05.006. Epub 2018 May 24. Review.

PMID:
29880258
2.

Early diagnosis of tuberous sclerosis complex: a race against time. How to make the diagnosis before seizures?

Słowińska M, Jóźwiak S, Peron A, Borkowska J, Chmielewski D, Sadowski K, Jurkiewicz E, Vignoli A, La Briola F, Canevini MP, Kotulska-Jóźwiak K.

Orphanet J Rare Dis. 2018 Jan 29;13(1):25. doi: 10.1186/s13023-018-0764-z.

3.

Management of epilepsy associated with tuberous sclerosis complex (TSC): clinical recommendations.

Curatolo P, Jóźwiak S, Nabbout R; TSC Consensus Meeting for SEGA and Epilepsy Management.

Eur J Paediatr Neurol. 2012 Nov;16(6):582-6. doi: 10.1016/j.ejpn.2012.05.004. Epub 2012 Jun 12. Review.

PMID:
22695035
4.

Mechanistic target of rapamycin (mTOR) in tuberous sclerosis complex-associated epilepsy.

Curatolo P.

Pediatr Neurol. 2015 Mar;52(3):281-9. doi: 10.1016/j.pediatrneurol.2014.10.028. Epub 2014 Nov 20. Review.

PMID:
25591831
5.

Tuberous sclerosis complex as a model disease for developing new therapeutics for epilepsy.

Jeong A, Wong M.

Expert Rev Neurother. 2016;16(4):437-47. doi: 10.1586/14737175.2016.1151788. Epub 2016 Feb 29. Review.

PMID:
26854692
6.

Epileptic spasms in tuberous sclerosis complex.

Hsieh DT, Jennesson MM, Thiele EA.

Epilepsy Res. 2013 Sep;106(1-2):200-10. doi: 10.1016/j.eplepsyres.2013.05.003. Epub 2013 Jun 21.

PMID:
23796861
7.

Everolimus treatment of refractory epilepsy in tuberous sclerosis complex.

Krueger DA, Wilfong AA, Holland-Bouley K, Anderson AE, Agricola K, Tudor C, Mays M, Lopez CM, Kim MO, Franz DN.

Ann Neurol. 2013 Nov;74(5):679-87. doi: 10.1002/ana.23960. Epub 2013 Sep 10.

PMID:
23798472
8.

Epilepsy in children with tuberous sclerosis complex: Chance of remission and response to antiepileptic drugs.

Overwater IE, Bindels-de Heus K, Rietman AB, Ten Hoopen LW, Vergouwe Y, Moll HA, de Wit MC.

Epilepsia. 2015 Aug;56(8):1239-45. doi: 10.1111/epi.13050. Epub 2015 Jun 4.

9.

Epilepsy in TSC: certain etiology does not mean certain prognosis.

Vignoli A, La Briola F, Turner K, Scornavacca G, Chiesa V, Zambrelli E, Piazzini A, Savini MN, Alfano RM, Canevini MP.

Epilepsia. 2013 Dec;54(12):2134-42. doi: 10.1111/epi.12430. Epub 2013 Nov 8.

10.

Lacosamide use in the treatment of refractory epilepsy in tuberous sclerosis complex.

Geffrey AL, Belt OD, Paolini JL, Thiele EA.

Epilepsy Res. 2015 May;112:72-5. doi: 10.1016/j.eplepsyres.2015.02.008. Epub 2015 Feb 16.

PMID:
25847341
11.

Current concepts on epilepsy management in tuberous sclerosis complex.

Canevini MP, Kotulska-Jozwiak K, Curatolo P, La Briola F, Peron A, Słowińska M, Strzelecka J, Vignoli A, Jóźwiak S.

Am J Med Genet C Semin Med Genet. 2018 Sep;178(3):299-308. doi: 10.1002/ajmg.c.31652. Epub 2018 Sep 26. Review.

PMID:
30255982
12.

Seizure remission and antiepileptic drug discontinuation in children with tuberous sclerosis complex.

Sparagana SP, Delgado MR, Batchelor LL, Roach ES.

Arch Neurol. 2003 Sep;60(9):1286-9.

PMID:
12975296
13.

Everolimus in tuberous sclerosis patients with intractable epilepsy: a treatment option?

Wiegand G, May TW, Ostertag P, Boor R, Stephani U, Franz DN.

Eur J Paediatr Neurol. 2013 Nov;17(6):631-8. doi: 10.1016/j.ejpn.2013.06.002. Epub 2013 Jul 8.

PMID:
23845174
14.

Long-term outcomes of resective epilepsy surgery after invasive presurgical evaluation in children with tuberous sclerosis complex and bilateral multiple lesions.

Arya R, Tenney JR, Horn PS, Greiner HM, Holland KD, Leach JL, Gelfand MJ, Rozhkov L, Fujiwara H, Rose DF, Franz DN, Mangano FT.

J Neurosurg Pediatr. 2015 Jan;15(1):26-33. doi: 10.3171/2014.10.PEDS14107.

PMID:
25360852
15.

[The Efficacy of Everolimus for Refractory Seizures in Childhood Onset Epilepsy with Tuberous Sclerosis Complex].

Okanishi T, Fujimoto A, Nishimura M, Baba S, Itamura S, Okanari K, Enoki H.

Brain Nerve. 2019 Jun;71(6):611-616. doi: 10.11477/mf.1416201323. Japanese.

PMID:
31171758
16.

Management of epilepsy in tuberous sclerosis complex.

Curatolo P, D'Argenzio L, Cerminara C, Bombardieri R.

Expert Rev Neurother. 2008 Mar;8(3):457-67. doi: 10.1586/14737175.8.3.457.

PMID:
18345974
17.

Efficacy and safety of Everolimus in children with TSC - associated epilepsy - Pilot data from an open single-center prospective study.

Samueli S, Abraham K, Dressler A, Gröppel G, Mühlebner-Fahrngruber A, Scholl T, Kasprian G, Laccone F, Feucht M.

Orphanet J Rare Dis. 2016 Nov 3;11(1):145.

18.

Early Detection of Tuberous Sclerosis Complex: An Opportunity for Improved Neurodevelopmental Outcome.

Chung CWT, Lawson JA, Sarkozy V, Riney K, Wargon O, Shand AW, Cooper S, King H, Kennedy SE, Mowat D.

Pediatr Neurol. 2017 Nov;76:20-26. doi: 10.1016/j.pediatrneurol.2017.05.014. Epub 2017 May 26.

PMID:
28811058
19.

Everolimus for epilepsy and autism spectrum disorder in tuberous sclerosis complex: EXIST-3 substudy in Japan.

Mizuguchi M, Ikeda H, Kagitani-Shimono K, Yoshinaga H, Suzuki Y, Aoki M, Endo M, Yonemura M, Kubota M.

Brain Dev. 2019 Jan;41(1):1-10. doi: 10.1016/j.braindev.2018.07.003. Epub 2018 Jul 27.

20.

[Efficacy and safety of rapamycin in treatment of children with epilepsy complicated with tuberous sclerosis].

Zou L, Liu Y, Pang L, Ju J, Shi Z, Zhang J, Chen X, Su X, Hu L, Shi X, Yang X.

Zhonghua Er Ke Za Zhi. 2014 Nov;52(11):812-6. Chinese.

PMID:
25582464

Supplemental Content

Support Center